N@N

Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $474 on, Oct 1st, 2024

Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Increased Target from $462 to $474 on, Oct 1st, 2024.

Matthew has made no other calls on VRTX in the last 4 months.

There are 15 other peers that have a rating on VRTX. Out of the 15 peers that are also analyzing VRTX, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $431 on, Thursday, September 19th, 2024
• Gena Wang of "Barclays" Downgraded from Buy to Hold and Increased Target to $509 on, Monday, August 5th, 2024
• Joseph Stringer of "Needham" Reiterated at Hold on, Friday, July 26th, 2024

These are the ratings of the 12 analyists that currently disagree with Matthew

---

• Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $550 on, Monday, August 5th, 2024
• Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $510 on, Monday, August 5th, 2024
• Joon Lee of "Truist Securities" Reiterated at Strong Buy with Increased Target to $550 on, Monday, August 5th, 2024
• Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $600 on, Monday, August 5th, 2024
• Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $480 on, Friday, August 2nd, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $535 on, Friday, August 2nd, 2024
• Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $558 on, Friday, August 2nd, 2024
• Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell with Increased Target to $376 on, Wednesday, July 31st, 2024
• Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Increased Target to $500 on, Tuesday, July 23rd, 2024
• Steve Chesney of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $545 on, Thursday, June 27th, 2024
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
• Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024

Contributing Sources

---